Aerts JGJV - Search Results

1

Microenvironment-Dependent Gradient of CTL Exhaustion in the AE17sOVA Murine Mesothelioma Tumor Model.

Hope JL, Spantidea PI, Kiernan CH, Stairiker CJ, Rijsbergen LC, van Meurs M, Brouwers-Haspels I, Mueller YM, Nelson DJ, Bradley LM, Aerts JGJV, Katsikis PD. Hope JL, et al. Among authors: aerts jgjv. Front Immunol. 2020 Jan 10;10:3074. doi: 10.3389/fimmu.2019.03074. eCollection 2019. Front Immunol. 2020. PMID: 31998326 Free PMC article.

2

Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells.

Hegmans JP, Hemmes A, Aerts JG, Hoogsteden HC, Lambrecht BN. Hegmans JP, et al. Am J Respir Crit Care Med. 2005 May 15;171(10):1168-77. doi: 10.1164/rccm.200501-057OC. Epub 2005 Mar 11. Am J Respir Crit Care Med. 2005. PMID: 15764728

3

Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma.

Hegmans JP, Veltman JD, Lambers ME, de Vries IJ, Figdor CG, Hendriks RW, Hoogsteden HC, Lambrecht BN, Aerts JG. Hegmans JP, et al. Am J Respir Crit Care Med. 2010 Jun 15;181(12):1383-90. doi: 10.1164/rccm.200909-1465OC. Epub 2010 Feb 18. Am J Respir Crit Care Med. 2010. PMID: 20167848 Clinical Trial.

4

New roads open up for implementing immunotherapy in mesothelioma.

Cornelissen R, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Aerts JG, Hegmans JP. Cornelissen R, et al. Clin Dev Immunol. 2012;2012:927240. doi: 10.1155/2012/927240. Epub 2012 Jun 24. Clin Dev Immunol. 2012. PMID: 22778767 Free PMC article. Review.

5

Dendritic cell-based immunotherapy in mesothelioma.

Cornelissen R, Lievense LA, Heuvers ME, Maat AP, Hendriks RW, Hoogsteden HC, Hegmans JP, Aerts JG. Cornelissen R, et al. Immunotherapy. 2012 Oct;4(10):1011-22. doi: 10.2217/imt.12.108. Immunotherapy. 2012. PMID: 23148753 Review.

6

Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer.

Aerts JG, Hegmans JP. Aerts JG, et al. Cancer Res. 2013 Apr 15;73(8):2381-8. doi: 10.1158/0008-5472.CAN-12-3932. Epub 2013 Apr 11. Cancer Res. 2013. PMID: 23580578 Review.

7

Checkpoint Blockade in Lung Cancer and Mesothelioma.

Lievense LA, Sterman DH, Cornelissen R, Aerts JG. Lievense LA, et al. Am J Respir Crit Care Med. 2017 Aug 1;196(3):274-282. doi: 10.1164/rccm.201608-1755CI. Am J Respir Crit Care Med. 2017. PMID: 28252315 Review.

8

Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy.

Dammeijer F, Lievense LA, Kaijen-Lambers ME, van Nimwegen M, Bezemer K, Hegmans JP, van Hall T, Hendriks RW, Aerts JG. Dammeijer F, et al. Cancer Immunol Res. 2017 Jul;5(7):535-546. doi: 10.1158/2326-6066.CIR-16-0309. Epub 2017 May 23. Cancer Immunol Res. 2017. PMID: 28536100

9

Autologous Dendritic Cells Pulsed with Allogeneic Tumor Cell Lysate in Mesothelioma: From Mouse to Human.

Aerts JGJV, de Goeje PL, Cornelissen R, Kaijen-Lambers MEH, Bezemer K, van der Leest CH, Mahaweni NM, Kunert A, Eskens FALM, Waasdorp C, Braakman E, van der Holt B, Vulto AG, Hendriks RW, Hegmans JPJJ, Hoogsteden HC. Aerts JGJV, et al. Clin Cancer Res. 2018 Feb 15;24(4):766-776. doi: 10.1158/1078-0432.CCR-17-2522. Epub 2017 Dec 12. Clin Cancer Res. 2018. PMID: 29233904 Clinical Trial.

10

Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.

Minnema-Luiting J, Vroman H, Aerts J, Cornelissen R. Minnema-Luiting J, et al. Int J Mol Sci. 2018 Mar 30;19(4):1041. doi: 10.3390/ijms19041041. Int J Mol Sci. 2018. PMID: 29601534 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters